GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GRAL GRAIL, Inc.

已收盘 03-19 16:00:00 EDT

48.47

+0.06

+0.12%

盘后48.47

+0.000.00%

19:34 EDT

最高49.75	最低46.60	成交量70.15万
今开47.33	昨收48.41	日振幅6.51%
总市值19.88亿	流通市值16.57亿	总股本4,102万
成交额3,376万	换手率2.05%	流通股本3,419万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":48.47,"timestamp":1773950400000,"preClose":48.41,"halted":0,"volume":701507,"hourTrading":{"tag":"盘后","latestPrice":48.47,"preClose":48.47,"latestTime":"19:34 EDT","volume":18357,"amount":889801.934,"timestamp":1773963259001,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0012394133443503878,"floatShares":34193700,"shares":41020255,"eps":-11.110457,"marketStatus":"已收盘","change":0.06,"latestTime":"03-19 16:00:00 EDT","open":47.33,"high":49.7533,"low":46.6,"amount":33755955.6344,"amplitude":0.065137,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.110457,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773993600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":48.41,"preHourTrading":{"tag":"盘前","latestPrice":47.53,"preClose":48.41,"latestTime":"09:27 EDT","volume":1308,"amount":61897.65996,"timestamp":1773926860058,"change":-0.88,"changeRate":-0.018178,"amplitude":0.050401},"postHourTrading":{"tag":"盘后","latestPrice":48.47,"preClose":48.47,"latestTime":"19:34 EDT","volume":18357,"amount":889801.934,"timestamp":1773963259001,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.650613,"impliedVol":0.9761,"impliedVolPercentile":0.49},"requestUrl":"/m/hq/s/GRAL","defaultTab":"news","newsList":[{"id":"2618819906","title":"Grail, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618819906","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618819906?lang=zh_cn&edition=full","pubTime":"2026-03-11 23:29","pubTimestamp":1773242953,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日23时29分，Grail, Inc.股票出现异动，股价大幅下跌5.01%。截至发稿，该股报46.23美元/股，成交量26.3417万股，换手率0.65%，振幅4.83%。Grail, Inc.股票所在的生命科学行业中，整体跌幅为0.79%。其相关个股中，Bioaffinity Technologies Inc C/Wts 07/09/2027 、Xwell, Inc.、Prenetics Global涨幅较大，Mainz Biomed N.V.、Xwell, Inc.、Bioaffinity Technologies, Inc.较为活跃，换手率分别为38.81%、10.07%、7.91%，振幅较大的相关个股有Xwell, Inc.、Inotiv, Inc.、Prenetics Global，振幅分别为17.14%、16.50%、12.29%。Grail, Inc.公司简介：GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311232913a461a2a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311232913a461a2a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2612298036","title":"Grail公司的多癌检测测试未达目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2612298036","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612298036?lang=zh_cn&edition=full","pubTime":"2026-02-20 23:12","pubTimestamp":1771600320,"startTime":"0","endTime":"0","summary":"专注于开发基于血液检测的癌症筛查技术的生物科技公司Grail公司（GRAL）的 Galleri 检测在一项大型英国国家医疗服务体系研究中未能达到主要终点，这对早期多癌检测血液检测来说是一个挫折；该公司报告称2025年售出了185000次检测。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-20/doc-inhnnssa5719078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"1147942002","title":"Grail盘前暴跌47%，罪魁祸首是这些检测结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1147942002","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147942002?lang=zh_cn&edition=full","pubTime":"2026-02-20 17:32","pubTimestamp":1771579965,"startTime":"0","endTime":"0","summary":"生物科技公司Grail盘前交易中股价暴跌47%，此前该公司癌症试验结果令投资者失望。Galleri是一种由Grail开发的血液检测，用于在癌症出现症状前筛查多种癌症。收盘后股价暴跌48%至52.25美元；截至周四收盘，该股在过去六个月已上涨逾200%。Grail于1月向美国食品药品监督管理局提交了上市前批准申请。公司补充称，提交材料中包含了NHS试验第一年的结果。Grail第四季度每股亏损2.44美元，好于预期；营收4360万美元，与华尔街预估基本一致。","market":"us","thumbnail":"https://static.tigerbbs.com/516cbe31098a2a42f16da93a5544fbb1","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/516cbe31098a2a42f16da93a5544fbb1"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3aff9350c4e69a79fb71d36941587b32","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"gpt_icon":1},{"id":"1152034500","title":"异动解读 | 第四季度财报亏损且核心癌症测试未达目标，GRAIL公司盘前大跌47.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152034500","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152034500?lang=zh_cn&edition=full","pubTime":"2026-02-20 17:11","pubTimestamp":1771578683,"startTime":"0","endTime":"0","summary":"GRAIL公司(GRAL)今日盘前股价大跌47.5%，引发了市场的广泛关注。消息面上，公司发布的第四季度财报显示净亏损为9920万美元，较上一季度有所增加。同时，公司宣布其关键的多种癌症早期检测试验Galleri未能达到在统计学上显著降低晚期癌症诊断率的主要研究目标，尽管在部分致命癌症中观察到了积极趋势。这一双重负面消息严重打击了投资者信心。Galleri测试是GRAIL公司的核心产品，其临床试验结果未达主要终点，引发了市场对公司未来增长前景和产品商业化潜力的深度担忧，直接导致了股价在盘前交易时段的大幅下挫。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3aff9350c4e69a79fb71d36941587b32","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"gpt_icon":0},{"id":"1188289893","title":"异动解读 | 第四季度财报亏损且癌症测试未达目标，GRAIL公司夜盘大跌47.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188289893","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188289893?lang=zh_cn&edition=full","pubTime":"2026-02-20 09:04","pubTimestamp":1771549446,"startTime":"0","endTime":"0","summary":"GRAIL公司(GRAL)今日夜盘股价大跌47.49%，引发了市场的广泛关注。消息面上，公司发布了第四季度财报，显示净亏损为9920万美元，较上一季度有所增加。同时，公司宣布其关键的多种癌症早期检测试验Galleri未能达到在统计学上显著降低晚期癌症诊断率的主要研究目标，尽管在部分致命癌症中观察到了积极趋势。这一双重负面消息严重打击了投资者信心。Galleri测试是GRAIL公司的核心产品，其临床试验结果未达主要终点，引发了市场对公司未来增长前景和产品商业化潜力的深度担忧，直接导致了股价在夜盘交易时段的大幅下挫。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"gpt_icon":0},{"id":"1158231115","title":"异动解读 | 第四季度财报亏损且癌症测试未达目标，GRAIL公司盘后大跌33.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158231115","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158231115?lang=zh_cn&edition=full","pubTime":"2026-02-20 05:47","pubTimestamp":1771537653,"startTime":"0","endTime":"0","summary":"GRAIL公司(GRAL)今日盘后股价大跌33.22%，引发了市场的广泛关注。消息面上，公司发布了第四季度财报，显示净亏损为9920万美元，较上一季度有所增加。同时，公司宣布其关键的多种癌症早期检测试验Galleri未能达到在统计学上显著降低晚期癌症诊断率的主要研究目标，尽管在部分致命癌症中观察到了积极趋势。这一双重负面消息严重打击了投资者信心。Galleri测试是GRAIL公司的核心产品，其临床试验结果未达主要终点，引发了市场对公司未来增长前景和产品商业化潜力的担忧，直接导致了股价在盘后交易时段的大幅下挫。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"gpt_icon":0},{"id":"1127672767","title":"里程碑式NHS-Galleri试验显示：IV期癌症诊断大幅减少，I/II期致命癌症检出率提升，癌症总体检出率激增四倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1127672767","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127672767?lang=zh_cn&edition=full","pubTime":"2026-02-20 05:02","pubTimestamp":1771534933,"startTime":"0","endTime":"0","summary":"具有里程碑意义的NHS-Galleri试验取得突破性成果。数据显示，该检测方法显著降低了IV期癌症的诊断比例。同时，针对致命性癌症的早期筛查能力大幅提升——I期和II期癌症检出率明显增加。更令人瞩目的是，整体癌症检测灵敏度达到常规方法的四倍以上。这项突破为癌症早筛领域带来全新可能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2603665104","title":"Grail, Inc.盘中异动 早盘急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603665104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603665104?lang=zh_cn&edition=full","pubTime":"2026-01-13 23:09","pubTimestamp":1768316992,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日23时09分，Grail, Inc.股票出现异动，股价大幅跳水5.04%。截至发稿，该股报100.59美元/股，成交量9.7776万股，换手率0.25%，振幅4.06%。Grail, Inc.股票所在的生命科学行业中，整体跌幅为0.23%。其相关个股中，Revvity, Inc.、Ispecimen Inc.、Twist Bioscience Corporation涨幅较大，Biodesix, Inc.、Ispecimen Inc.、Mainz Biomed N.V.较为活跃，换手率分别为7.03%、4.83%、0.60%，振幅较大的相关个股有Ispecimen Inc.、Precipio, Inc.、Biodesix, Inc.，振幅分别为12.76%、12.47%、8.54%。Grail, Inc.公司简介：GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113230953a7165d3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113230953a7165d3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDSX","GRAL","BK4139","BK4196"],"gpt_icon":0},{"id":"2584737239","title":"Grail, Inc.盘中异动 股价大涨5.09%报85.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584737239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584737239?lang=zh_cn&edition=full","pubTime":"2025-11-19 23:19","pubTimestamp":1763565580,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日23时19分，Grail, Inc.股票出现波动，股价急速拉升5.09%。截至发稿，该股报85.60美元/股，成交量12.1746万股，换手率0.31%，振幅6.41%。Grail, Inc.股票所在的生命科学行业中，整体跌幅为0.09%。其相关个股中，Inotiv, Inc.、Prophase Labs, Inc.、Personalis, Inc.涨幅较大，Mainz Biomed N.V.、Inotiv, Inc.、Prophase Labs, Inc.较为活跃，换手率分别为4.56%、1.74%、1.50%，振幅较大的相关个股有Mainz Biomed N.V.、Inotiv, Inc.、Endra Life Sciences Inc.，振幅分别为16.58%、13.76%、8.82%。Grail, Inc.公司简介：GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119231940a704ad57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119231940a704ad57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"1110370871","title":"异动解读 | 医疗科技公司Grail股价盘中大涨5.22%，受益于分析师目标价上调","url":"https://stock-news.laohu8.com/highlight/detail?id=1110370871","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110370871?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:52","pubTimestamp":1763391140,"startTime":"0","endTime":"0","summary":"周一盘中，医疗科技公司Grail Inc股价大涨5.22%，引发市场关注。这一显著涨幅主要受益于券商分析师的积极评估。据悉，知名投资银行Canaccord Genuity当日大幅上调了Grail的目标股价，从此前的85美元提高至105美元，涨幅高达23.5%。这一举动表明分析师对Grail公司未来发展前景持乐观态度，从而提振了投资者信心。Grail公司专注于开发早期癌症检测技术，其创新的液体活检技术有望在癌症早期诊断领域取得突破。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"gpt_icon":0},{"id":"1169508049","title":"异动解读 | GRAIL股价盘中大涨7.43%，古根海姆上调评级至\"买入\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1169508049","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169508049?lang=zh_cn&edition=full","pubTime":"2025-11-12 23:12","pubTimestamp":1762960345,"startTime":"0","endTime":"0","summary":"周三盘中，生物技术公司GRAIL, Inc.股价大涨7.43%，引发市场关注。这一显著涨幅主要受益于华尔街知名投行古根海姆的最新研究报告。古根海姆将GRAIL的股票评级从\"中性\"上调至\"买入\"，并给出100美元的目标价。值得注意的是，古根海姆强调，相比竞争对手，GRAIL具备显著的潜在数据壁垒。这一优势可能是推动投资者信心和股价上涨的关键因素。随着癌症早期检测市场的不断扩大，GRAIL的市场地位和技术优势可能会为公司带来长期增长潜力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"gpt_icon":0},{"id":"2582308381","title":"华尔街顶级分析师最新评级报告：美国电话电报公司评级上调","url":"https://stock-news.laohu8.com/highlight/detail?id=2582308381","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582308381?lang=zh_cn&edition=full","pubTime":"2025-11-12 23:05","pubTimestamp":1762959900,"startTime":"0","endTime":"0","summary":"华尔街最受关注、且能影响市场走势的研究评级报告现已汇总一处。KeyBanc 银行将美国电话电报公司的评级从 “行业权重” 上调至 “增持”，目标股价定为 30 美元。伯恩斯坦公司首次覆盖辛塔斯公司，给予 “与大盘持平” 评级，目标股价定为 200 美元。该机构认为，辛塔斯是一家 “优质成长型公司”，但当前股价已处于高位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-11-12/doc-infxemns6034755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["T","LU1621768115.EUR","LU2506951958.HKD","LU1621767810.EUR","BK4162","LU2506952170.USD","PGNY","BK4503","LU0175139822.USD","BK4142","LU1861558580.USD","NUVL","BK4214","LU1571399168.USD","ATAT","BBWI","BK4234","BK4588","QUIK","LU1169589451.USD","BK4598","BK4200","BK4535","BK4550","FND","BK4137","KMX","AN","IE00BSNM7G36.USD","BK4215","CVNA","LU0211326839.USD","BK4534","LU0650527681.SGD","BK4141","BK4556","LU0823417653.USD","LU1621768206.USD","BK4154","BK4548","OUT","BK4139","LU1169590202.USD","CTAS","NTLA","BHF","BK4585","GRAL","BK4507","CSR"],"gpt_icon":0},{"id":"2582338901","title":"Grail, Inc.盘中异动 早盘股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582338901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582338901?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:31","pubTimestamp":1762785111,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时31分，Grail, Inc.股票出现波动，股价大幅拉升5.46%。截至发稿，该股报83.74美元/股，成交量2.1143万股，换手率0.06%，振幅1.01%。Grail, Inc.股票所在的生命科学行业中，整体涨幅为0.21%。其相关个股中，Personalis, Inc.、Billiontoone, Inc.、Prenetics Global涨幅较大，Check-Cap Ltd.、Personalis, Inc.、Advanced Biomed Inc.较为活跃，换手率分别为0.56%、0.20%、0.19%，振幅较大的相关个股有Billiontoone, Inc.、Personalis, Inc.、Prenetics Global，振幅分别为8.47%、8.23%、4.62%。Grail, Inc.公司简介：GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223151a6efbe06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223151a6efbe06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2581493800","title":"Grail, Inc.盘中异动 急速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581493800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581493800?lang=zh_cn&edition=full","pubTime":"2025-11-06 23:37","pubTimestamp":1762443472,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日23时37分，Grail, Inc.股票出现波动，股价快速跳水5.09%。Grail, Inc.股票所在的生命科学行业中，整体跌幅为0.45%。其相关个股中，查尔斯河实验室、Precipio, Inc.、Prophase Labs, Inc.涨幅较大，Bioaffinity Technologies, Inc.、Advanced Biomed Inc.、Exagen Inc.较为活跃，换手率分别为1.48%、1.11%、0.74%，振幅较大的相关个股有Advanced Biomed Inc.、Caredx, Inc.、Check-Cap Ltd.，振幅分别为10.14%、9.01%、7.06%。Grail, Inc.公司简介：GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106233752975879ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106233752975879ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL","BK4198","ADVB"],"gpt_icon":0},{"id":"2576509878","title":"GRAIL宣布进行3.25亿美元的股票发行","url":"https://stock-news.laohu8.com/highlight/detail?id=2576509878","media":"环球市场播报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576509878?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:59","pubTimestamp":1760968740,"startTime":"0","endTime":"0","summary":"美股周一早盘，生物科技公司GRAIL（GRAL）股价大涨23%，此前该公司宣布进行3.25亿美元的股票发行，以资助其商业和报销活动。公司预计此次募资加之三星的1.1亿美元投资将支持其运营至2030年。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-10-20/doc-infuqfte3539350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","SINA","GRAL"],"gpt_icon":0},{"id":"1176533861","title":"Grail Pathfinder 2结果显示，Galleri®多癌种早期检测血液测试在增加USPSTF A和B推荐筛查时，癌症检测率提升超过七倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1176533861","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176533861?lang=zh_cn&edition=full","pubTime":"2025-10-18 06:10","pubTimestamp":1760739011,"startTime":"0","endTime":"0","summary":"Grail Pathfinder 2结果显示，Galleri®多癌种早期检测血液测试在增加USPSTF A和B推荐筛查时，癌症检测率提升超过七倍","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"1113432422","title":"Grail Inc：预计截至9月30日拥有约5.47亿美元的现金、现金等价物、限制性现金和短期可投资证券","url":"https://stock-news.laohu8.com/highlight/detail?id=1113432422","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113432422?lang=zh_cn&edition=full","pubTime":"2025-10-17 05:08","pubTimestamp":1760648909,"startTime":"0","endTime":"0","summary":"Grail Inc：预计截至9月30日拥有约5.47亿美元的现金、现金等价物、限制性现金和短期可投资证券。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"1155050093","title":"Grail Inc：预计截至2025年9月30日的三个月收入在3570万到3670万美元之间","url":"https://stock-news.laohu8.com/highlight/detail?id=1155050093","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155050093?lang=zh_cn&edition=full","pubTime":"2025-10-17 05:06","pubTimestamp":1760648767,"startTime":"0","endTime":"0","summary":"Grail Inc：预计截至2025年9月30日的三个月收入在3570万到3670万美元之间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2575446607","title":"Grail(GRAL)盘前涨近12% 与三星达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2575446607","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575446607?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:28","pubTimestamp":1760621289,"startTime":"0","endTime":"0","summary":"金吾财讯 | Grail(GRAL)盘前股价拉升，暂报84.5美元，涨11.85%。消息面上，三星与Grail宣布达成战略合作，将Grail的Galleri®多癌早筛检测引入亚洲。三星物产和三星电子将向Grail投资1.1亿美元。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/MmNlMmI2NWNjNWI2MzQ2MDk3MTI0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/MmNlMmI2NWNjNWI2MzQ2MDk3MTI0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4938b0cb8d08e9f7c72e7da79caa4313","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"293507","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"1168467442","title":"三星与GRAIL战略合作，将癌症早期检测测试引入亚洲","url":"https://stock-news.laohu8.com/highlight/detail?id=1168467442","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168467442?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:50","pubTimestamp":1760619022,"startTime":"0","endTime":"0","summary":"三星子公司同意对该公司进行投资。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c14b607a2ef729dba99d9e6cdeff3225","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://grail.com;investors.grail.com","stockEarnings":[{"period":"1week","weight":0.0449},{"period":"1month","weight":-0.5035},{"period":"3month","weight":-0.4518},{"period":"6month","weight":0.1623},{"period":"1year","weight":0.7179},{"period":"ytd","weight":-0.4344}],"compareEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":-0.0298},{"period":"3month","weight":-0.0222},{"period":"6month","weight":-0.0034},{"period":"1year","weight":0.179},{"period":"ytd","weight":-0.03}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Grail, Inc.于2015年9月11日在特拉华州注册成立。该公司是一家医疗保健公司，致力于通过开创癌症早期检测的新技术来拯救生命和改善健康。该公司建立了一个由科学家、工程师和医生组成的多学科组织，它正利用下一代测序（NGS）、人群规模临床研究以及最先进的计算机科学和数据科学的力量来克服医学的最大挑战之一。该公司利用该公司的平台技术，开发了一种多癌症早期检测血液检测方法，在临床研究中证明了从一次抽血中就可以检测出50多种癌症类型，并能高度准确地定位癌症信号。","exchange":"NASDAQ","name":"GRAIL, Inc.","nameEN":"GRAIL, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GRAIL, Inc.(GRAL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GRAIL, Inc.,GRAL,GRAIL, Inc.股票,GRAIL, Inc.股票老虎,GRAIL, Inc.股票老虎国际,GRAIL, Inc.行情,GRAIL, Inc.股票行情,GRAIL, Inc.股价,GRAIL, Inc.股市,GRAIL, Inc.股票价格,GRAIL, Inc.股票交易,GRAIL, Inc.股票购买,GRAIL, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GRAIL, Inc.(GRAL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}